These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36906183)

  • 1. Mass spectrometry-based assessment of prostate cancer-associated crystalloids reveals enrichment for growth and differentiation factor 15.
    Tekin B; Dasari S; Theis JD; Vrana JA; Murray DL; Oglesbee D; Thompson RH; Leibovich BC; Boorjian SA; Whaley RD; Hernandez LH; Jimenez RE; Cheville JC; Karnes RJ; Sukov WR; Gupta S
    Hum Pathol; 2023 May; 135():35-44. PubMed ID: 36906183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy.
    Henneberry JM; Kahane H; Humphrey PA; Keetch DW; Epstein JI
    Am J Surg Pathol; 1997 Jun; 21(6):725-8. PubMed ID: 9199652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraluminal crystalloids in whole-organ sections of prostate.
    Ro JY; Grignon DJ; Troncoso P; Ayala AG
    Prostate; 1988; 13(3):233-9. PubMed ID: 3211805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of intraluminal prostatic crystalloids in benign needle biopsies.
    Anton RC; Chakraborty S; Wheeler TM
    Am J Surg Pathol; 1998 Apr; 22(4):446-9. PubMed ID: 9537472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe x-ray microanalytic study.
    Del Rosario AD; Bui HX; Abdulla M; Ross JS
    Hum Pathol; 1993 Nov; 24(11):1159-67. PubMed ID: 8244315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic corpora amylacea and crystalloids: similarities and differences on ultrastructural and histochemical studies.
    Drachenberg CB; Papadimitriou JC
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):141-50. PubMed ID: 8964038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural heterogenity of intraluminal content of the prostate: a histochemical and ultrastructural study.
    Badea P; Petrescu A; Moldovan L; Zarnescu O
    Microsc Microanal; 2015 Apr; 21(2):368-76. PubMed ID: 25772314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.
    Cheung PK; Woolcock B; Adomat H; Sutcliffe M; Bainbridge TC; Jones EC; Webber D; Kinahan T; Sadar M; Gleave ME; Vielkind J
    Cancer Res; 2004 Sep; 64(17):5929-33. PubMed ID: 15342369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystalloids of prostatic carcinoma: relationship to Bence-Jones crystals.
    Holmes EJ
    Cancer; 1977 May; 39(5):2073-80. PubMed ID: 404025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns.
    Yaskiv O; Cao D; Humphrey PA
    Am J Surg Pathol; 2010 Apr; 34(4):556-61. PubMed ID: 20216381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraluminal crystalloids in prostatic adenocarcinoma. Immunohistochemical, electron microscopic, and x-ray microanalytic studies.
    Ro JY; Ayala AG; Ordonez NG; Cartwright J; Mackay B
    Cancer; 1986 Jun; 57(12):2397-407. PubMed ID: 3008982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
    Egan AJ; Lopez-Beltran A; Bostwick DG
    Am J Surg Pathol; 1997 Aug; 21(8):931-5. PubMed ID: 9255256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy.
    Levi AW; Epstein JI
    Am J Surg Pathol; 2000 Aug; 24(8):1039-46. PubMed ID: 10935644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yee DS; Narula N; Ramzy I; Boker J; Ahlering TE; Skarecky DW; Ornstein DK
    Arch Pathol Lab Med; 2007 Jun; 131(6):902-8. PubMed ID: 17550317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interplay of growth differentiation factor 15 (GDF15) expression and M2 macrophages during prostate carcinogenesis.
    Sadasivan SM; Chen Y; Gupta NS; Han X; Bobbitt KR; Chitale DA; Williamson SR; Rundle AG; Tang D; Rybicki BA
    Carcinogenesis; 2020 Aug; 41(8):1074-1082. PubMed ID: 32614434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 34 beta E-12 immunoreactivity in benign prostatic acini. Quantitation, pattern assessment, and electron microscopic study.
    Goldstein NS; Underhill J; Roszka J; Neill JS
    Am J Clin Pathol; 1999 Jul; 112(1):69-74. PubMed ID: 10396288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma.
    Cheville JC; Bostwick DG
    Am J Surg Pathol; 1995 Sep; 19(9):1068-76. PubMed ID: 7544958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathologic characteristics of pseudohyperplastic prostatic adenocarcinoma].
    Zhang HZ; Jiang ZM; Shi L
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):742-5. PubMed ID: 18307877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.